Quantitative determination of poly(amidoamine) dendrimers in urine by liquid chromatography/electrospray ionization hybrid quadrupole linear ion trap mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 22, 2013, Pages 2519-2529

  Uclés, Ana ^a,b   Martínez Bueno, María Jesús ^a   Ulaszewska, Maria Malgorzata ^b   Hernando, María Dolores ^c   Ferrer, Carmen ^a   Fernández Alba, Amadeo R ^a,b  

^a UNIVERSITY OF ALMERÍA   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c INIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CONTROLLED DRUG DELIVERY; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ALGEBRA; TARGETED DRUG DELIVERY;

LINEAR ION TRAP MASS SPECTROMETRIES; LIQUID CHROMATOGRAPHY ELECTROSPRAY; MONITORING MODE; NANO-SIZE; NANOCARRIERS; POLYAMIDOAMINE DENDRIMERS; QUADRUPOLES; QUANTITATIVE DETERMINATIONS; SELECTED REACTION MONITORING; SURFACE-MODIFICATION;

DENDRIMERS;

EID: 84885438448     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6713     Document Type: Article

References (41)

1. I. J. Majoros, J. R. Baker,. Dendrimer-Based Nanomedicine. Pan Stanford Publishing, Singapore, 2008.
2. F. Vögtle, G. Richardt, N. Werner,. Dendrimer Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2009.
3. A. R. Menjoge, R. M. Kannan, D. A. Tomalia,. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov. Today 2010, 15, 171.
4. A. D'Emanuel, R. Jevprasesphant, J. Penny, D. Attwood,. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J. Control. Release 2004, 95, 447.
5. M. L. Ma, Y. Y. Cheng, Z. H. Xu, P. Xu, H. Qu, Y. J. Fang, T. W. Xu, L. P. Wen,. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur. J. Med. Chem. 2007, 42, 93.
6. B. Devarakonda, D. P. Otto, A. Judefeind, R. A. Hill, M. M. de Villiers,. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes. Int. J. Pharm. 2007, 345, 142.
7. Hyperbranched Polymers. Synthesis, Properties and Applications, (Eds:, D. Yan, C. Gao, H. Frey,). John Wiley, Hoboken, NJ, USA, 2010.
8. C. Yiyun, X. Tongwen, F. Rongqiang,. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur. J. Med. Chem. 2005, 40, 1188.
9. R. N. Prajapati, R. K. Tekade, U. Gupta, V. Gajbhiye, N. K. Jain,. Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam. Mol. Pharm. 2009, 6, 940.
10. C. Yiyun, X. Tongwen,. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. Eur. J. Med. Chem. 2005, 40, 1384.
11. N. K. Jain, A. J. Khopade,. Dendrimers as Potential Delivery Systems for Bioactives. CBS Publishers & Distributors, New Delhi, 2001.
12. C. C. Lee, J. A. Mackay, M. J. Fréchet, F. C. Szoka,. Designing dendrimers for biological applications. Nat. Biotechnol. 2005, 23, 1517.
13. P. Szymanski, M. Markowicz, E. Mikiciuk-Olasik,. Nanotechnology in pharmaceutical and biomedical applications. Dendrimers. Nano 2011, 6, 509.
14. H. Kobayashi, M. W. Brechbiel,. Dendrimer-based macromolecular MRI contrast agents: Characteristics and application. Mol. Imaging 2003, 2, 1.
15. N. Sato, H. Kobayashi, A. Hiraga, T. Saga, K. Togashi, J. Konishi, M. W. Brechbiel,. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn. Reson. Med. 2001, 46, 1169.
16. S. Bai, C. Thomas, A. Rawat, F. Ahsan,. Recent progress in dendrimer-based nanocarriers. Crit. Rev. Ther. Drug. Carrier Syst. 2006, 23, 437.
17. A. M. Caminade, R. Laurent, J. P. Majoral,. Characterization of dendrimers. Adv. Drug Deliver. Rev. 2005, 57, 2130.
18. Y. H. Zhang, T. P. Thomas, A. Desai, H. Zong, P. R. Leroueil, I. J. Majoros, J. R. Baker,. Targeted dendrimeric anticancer prodrug: A methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, one pot synthetic approach. Bioconjugate Chem. 2010, 21, 489.
19. 13C NMR relaxation in poly(amido amine) starburst dendrimers. Abstracts Papers Am. Chem. Soc. 1989, 30, 121.
20. M. J. Jasmine, M. Kavitha, E. Prasad,. Effect of solvent-controlled aggregation on the intrinsic emission properties of PAMAM dendrimers. J. Lumin. 2009, 129, 506.
21. M. L. Ainalem, A. M. Carnerup, J. Janiak, V. Alfredsson, T. Nylander, K. Schillen,. Condensing DNA with poly-(amido amine) dendrimers of different generations: means of controlling aggregate morphology. Soft Matter 2009, 5, 2310.
22. M.-L. Orberg, K. Schillen, T. Nylander,. Dynamic light scattering and fluorescence study of the interaction between double-stranded DNA and poly(amido amine) dendrimers. Biomacromolecules 2007, 8, 1557.
23. M. T. Islam, X. Shi, L. Balogh, J. R. Baker,. HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups. Anal. Chem. 2005, 77, 2063.
24. J. Subbi, R. Aguraiuja, R. Tanner, V. Allikmaa, M. Lopp,. Fragmentation of poly(amidoamine) dendrimers in matrix-assisted laser desorption. Eur. Polym. J. 2005, 41, 2552.
25. A. Adhiya, C. Wesdemiotis,. Poly(propylene imine) dendrimer conformations in the gas phase: a tandem mass spectrometry study. Int. J. Mass Spectrom. 2002, 214, 75.
26. M. M. Ulaszewska, M. D. Hernando, A. Uclés, R. Rosal, A. Rodríguez, E. Garcia, A. R. Fernández-Alba,. Analysis and Risk of Nanomaterials in Environmental and Food Samples, (Ed:, D. Barcelõ,). Elsevier, The Netherlands, 2012.
27. C. L. Jackson, H. D. Chanzy, F. P. Booy, B. J. Drake, D. A. Tomalia, B. J. Bauer, E. J. Amis,. Visualization of dendrimer molecules by transmission electron microscopy (TEM): Staining methods and cryo-TEM of vitrified solutions. Macromolecules 1998, 31, 6259.
28. D. G Mullen, E. L Borgmeier, A. M Desai,. Isolation and characterization of dendrimers with precise numbers of functional groups. Chemistry 2010, 16, 10675.
29. C. A. Cason, T. A. Fabré, A. Buhrlage, K. L. Haik, H. A. Bullen,. Low-level detection of poly(amidoamine) PAMAM dendrimers using immunoimaging scanning probe microscopy. Int. J. Anal. Chem. 2012, DOI: 10.1155/IJAC.341260.
30. M. D. Hernando, P. Rosenkranz, M. M. Ulaszewska, M. L. Fernández-Cruz, A. R. Fernández-Alba, J. M. Navas,. In vitro dose-response effects of poly(amidoamine) dendrimers [amino-terminated and surface-modified with N-(2-hydroxydodecyl) groups] and quantitative determination by a liquid chromatography-hybrid quadrupole/time-of-flight mass spectrometry based method. Anal. Bioanal. Chem. 2012, 404, 2749.
31. A. Uclés, M. M. Ulaszewska, M. D. Hernando, M. J. Ramos, S. Herrera, E. García, A. R. Fernández-Alba,. Qualitative and quantitative analysis of poly(amidoamine) dendrimers in an aqueous matrix by liquid chromatography- electrospray ionization- hybrid quadrupole time-of-flight mass spectrometry (LC-ESI-QTOF-MS). Anal. Bioanal. Chem. 2013, 1. DOI: 10.1007/s00216-012-6673-4.
32. R. Giordanengo, M. Mazarin, J. Wu, L. Peng, L. Charles,. Propagation of structural deviations of poly(amidoamine) fan-shape dendrimers (generations 0-3) characterized by MALDI and electrospray mass spectrometry. Int. J. Mass Spectrom. 2007, 266, 62.
33. M. M. Ulaszewska, M. D. Hernando, A. Uclés Moreno, A. Valverde García, E. García Calvo, A. R. Fernández-Alba,. Identification and quantification of poly(amidoamine) PAMAM dendrimers of generations 0 to 3 by liquid chromatography/ hybrid quadrupole time-of-flight mass spectrometry in aqueous medium. Rapid Commun. Mass Spectrom. 2013, 27, 747.
34. M. J. M. Bueno, A. Agüera, M. D. Hernando, M. J. Gõmez, A. R. Fernández-Alba,. Evaluation of various liquid chromatography-quadrupole- linear ion trap-mass spectrometry operation modes applied to the analysis of organic pollutants in wastewaters. J. Chromatogr. A 2009, 1216, 5995.
35. R. Skibiński, M. Markowicz, P. Szymański, E. Mikiciuk-Olasik,. Identification of polyamidoamine dendrimers (PAMAM-NH2) by ESI-Q-TOF method. Curr. Issues Pharm. Med. Sci. 2012, 25, 286.
36. D. G. Mullen, A. Desai, M. A. von Dongen, M. Barash, J. R. Baker Jr, M. M. Banaszak Holl,. Best practices for purification and characterization of PAMAM dendrimer. Macromolecules 2012, 12, 5316.
37. M. A. Kaczorowska, H. J. Cooper,. Electron capture dissociation, electron detachment dissociation, and collision-induced dissociation of polyamidoamine (PAMAM) dendrimer ions with amino, amidoethanol, and sodium carboxylate surface groups. J. Am. Soc. Mass Spectrom. 2008, 19, 1312.
38. •,y cleavages in the electron capture dissociation mass spectrometry of polyamidoamine (PAMAM) dendrimer ions with amide functionalities. J. Am. Soc. Mass Spectrom. 2006, 17, 536.
39. E. Chambers, D. M. Wagrowski-Diehl, Z. Lu, J. R. Mazzeo,. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 2007, 852, 22.
40. D. Sviridov, G. L. Hortin,. Urine albumin measurement: Effects of urine matrix constituents. Clin. Chim. Acta 2009, 404, 140.
41. M. A. Johansson, K. E. Hellenas,. Matrix effects in immunobiosensor determination of clenbuterol in urine and serum. Analyst 2004, 129, 438.